top of page
Home_banner_3.jpg

Abstracts

These resources are for SETGYC Congress delegates only. Please do not share.

Abstracts

P54

Cell and gene therapy of Neural diseases

P Rodríguez-Cumbreras

Instituto de Biomedicina de Sevilla (IBiS); Universidad de Sevilla; Hospital Universitario Virgen del Rocío (HUVR); Consejo Superior de Investigaciones Científicas (CSIC)


Promoting brain regeneration through cellular reprogramming

P55

Cell and gene therapy of Neural diseases

J Sierra

Universidad Francisco de Vitoria; Universidad Autónoma de Madrid


Direct reprogramming of adult human olfactory ensheathing glia (OEG) into neurons

P56

Cell and gene therapy of Neural diseases

O Arnold

Biodonostia Institute


Investigation of RNA misregulation in TDP-43 proteinopathies identifies novel targets for disease diagnosis and monitorization

P57

Cell and gene therapy of Neural diseases

B Almolda

Institut de Neurociènces (INc), Universitat Autònoma Barcelona, Bellaterra, Spain; Vall d'Hebron Institut de Recerca (VHIR), Research Group on Gene Therapy at Nervous System, Passeig de la Vall d'Hebron, Barcelona, Spain


AAV-Mediated Expression of αKlotho Isoforms Rescues Relevant Aging Hallmarks in SAMP8 Mice

P58

Cell and gene therapy of skin, skeletal & cardiac muscles

J A Marchal 

Universidad de Granada; Instituto de Investigación Biosanitaria ibs.GRANADA; BioFab i3D - Biofabrication and 3D (bio)printing laboratory


3D bioprinting of a novel thermoplastic polyurethane material with potential for cartilage regenerative purposes

P59

Cell and gene therapy of skin, skeletal & cardiac muscles

A Voltes-Martínez 

Universidad de Granada


Mineralized Eggshell Membranes as an Osteoinductive Biomaterial for Bone Regenerative Medicine

P60

Cell and gene therapy of skin, skeletal & cardiac muscles

M Alvarez-Viejo

Cell Therapy and Regenerative Medicine Unit. Hematology and Hemotherapy Department. Central University Hospital of Asturias (HUCA). Health Research Institute of Asturias (ISPA). Oviedo. 33011. Spain.


Pressure ulcers’ treatment with a plasma scaffold containing mononuclear cells in an experimental model

P61

Cell and gene therapy of skin, skeletal & cardiac muscles

S Perez-Lopez

Cell Therapy and Regenerative Medicine Unit. Hematology and Hemotherapy Department. Central University Hospital of Asturias (HUCA). Health Research Institute of Asturias (ISPA). Oviedo. 33011. Spain.


Wound healing gene expression in a pressure ulcer animal model

P62

Cell and gene therapy of skin, skeletal & cardiac muscles

R Aguilar-Quesada

Coordinating Node, Andalusian Public Health System Biobank, Granada


Trehalose cryopreservation of human mesenchymal stem cells from cord and adipose tissue

P63

Gene editing clinical trials

F Larcher

Universidad Carlos III de Madrid (UC3M); CIEMAT/CIBERER; Instituto de Investigación Sanitaria de la Fundacion Jiménez Díaz (IIS-FJD)


Preclinical safety and complementary efficacy assessment of an advanced medicinal product for the treatment of recessive dystrophic Epidermolysis Bullosa by gene editing

P65

Gene delivery platform

P Martin-Duque

Instituto Aragonés de Ciencias de la Salud (IACS); Fundación Araid; IIS Aragón; Universidad de Zaragoza


Placental MSCs and their exosomes as vehicles for the Na/I symporter (hNIS): A new agent for gene therapy and diagnostic

P66

Gene delivery platform

P Martin-Duque

Instituto Aragonés de Ciencias de la Salud; Universidad de Zaragoza; IIS Aragón; Fundación Araid


Coating an adenovirus with functionalized gold nanoparticles favors uptake, intracellular trafficking and anti-cancer therapeutic efficacy

bottom of page